Sikora et al. assessed plasma claudin-3 and intestinal fatty acid binding protein (iFABP) levels in psoriatic patients, as they are considered non-invasive markers of gut barrier integrity; both were elevated and the level of iFABP correlated positively with psoriasis severity. This evidence concerns the gene CLDN3 and psoriasis.